Research shows that since 1982, new drugs provided an extra 150 million years of life—and that the United States led the way with 719 new drugs. This is nothing short of miraculous. For seniors, and for all Americans, it is impossible to put a price on living longer and living better. Sadly, that is exactly what H.R. 3 would do, to tragic effect.
Learn MoreWASHINGTON, D.C. — Commitment to Seniors, a project of American Commitment dedicated to protecting seniors’ healthcare interests, releases a new television advertisement condemning big government spending plans, which will come at the expense of seniors’ access to lifesaving medications. The ad criticizes Democrat politicians, including Bernie Sanders and Nancy Pelosi, for harming Medicare beneficiaries and filling the pockets of big health insurers. “Washington politicians are at it again, saying they want to reform Medicare…
Learn More
President Biden recently unveiled a new executive order on “Promoting Competition” in the U.S. economy. Though the executive order is purported to ‘up our game’ – its health care recommendations plainly drop the ball. If Biden’s agenda is enacted as articulated, it would put American medical innovation at enormous competitive disadvantage – and carry especially devastating consequences for our most vulnerable populations, including seniors. Biden’s EO states, “It is also the policy of my Administration…
Learn MoreWASHINGTON, D.C. – Commitment to Seniors, a project of American Commitment dedicated to protecting seniors’ healthcare interests, releases a new advertisement slamming H.R. 3. The digital video ad condemns H.R. 3, a bill that would impose restrictions on seniors’ access to cutting-edge medicines while also supplying health insurers with a substantial financial windfall. Currently airing in eighteen key Democratic districts, the ad excoriates Democrat politicians for supporting H.R. 3, potentially diverting billions from Medicare despite…
Learn More
Senator Chuck Grassley (R-Iowa) recently made waves claiming that pharmacy benefit managers (PBMs) are to blame for the volatility of insulin prices. It’s a bold statement, to be sure. But here’s the thing: the senator is absolutely right — and PolitiFact has confirmed as much. On January 31, 2021, PolitiFact partnered with The Daily Iowan to release a fact-check on Grassley’s statement, ultimately providing the senator with its highest rating of “True” on the organization’s Truth-O-Meter™. “With their complicated discount negotiations,” PolitiFact concludes, PBMs play a role in driving upward the cost…
Learn More
Robinhood was once a symbol of the Everyman’s triumph over brokerage fees, capital requirements, and other barriers that had locked potential retail investors out of the stock market. The company’s innovative investing platform represented a victory for democratizing finance. But through the firm’s ongoing GameStop scandal, that perception has changed. The controversy has shaken many individuals’ faith in their company. Now, people are understandably asking: Are organizations that purport to represent everyday people actually beholden…
Learn More
A lawsuit currently being pursued by Ohio Attorney General David Yost against OptumRx, a pharmacy benefit manager (PBM), alleges that the company bilked Ohio state coffers of more than $1.3 million on generic medications. If true, taxpayers and patients should be outraged. But this is far from the only reason to distrust PBMs. PBMs are the corporate middlemen that drive the costs of drugs up for patients in pursuit of their own profits. Seniors, in particular, who…
Learn More
The enthusiastically socialist Jacobin magazine recently took President Biden to task for a healthcare plan that superficially appeared “lifted” from insurance industry lobbyists. Of course, cribbing material is nothing new for Joe Biden—and neither is going to bat for Big Insurance at the expense of Americans. Jacobin reports, “Biden’s plan would shovel billions of dollars to private health insurers by providing subsidies for Americans to buy coverage through the Affordable Care Act (ACA) marketplaces… Those initiatives — which could further boost insurers’ skyrocketing profits — were…
Learn More